Cite
MLA Citation
M Calafat et al.. “P437 Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registry.” Journal of Crohn's and colitis, vol. 13, n.d., pp. S328–S329. http://access.bl.uk/ark:/81055/vdc_100094055577.0x00000e